Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NovaGray Logo
NovaGray Growth Score
36
CB Rank
215552
Heat Score
61
NovaGray is developing the first predictive tests establishing patients’ sensitivity towards radiotherapy.
Founded
obfuscation
PrivateGrant Montpellier, Languedoc-Roussillon, France11-50 www.nova-gray.com
Biotechnology
Health Care
Life Science
Overview

NovaGray
Total Funding
obfuscation
Growth Score
36
Heat Score
61

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score36
-24 pts
in past quarter
Heat Score 61
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NovaGray

CB Rank
215552
NovaGray is developing the first predictive tests establishing patients’ sensitivity towards radiotherapy.
Founded
obfuscation
PrivateGrant Montpellier, Languedoc-Roussillon, France11-50 www.nova-gray.com
Biotechnology
Health Care
Life Science

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Clemence Franc, David Azria
About the Company
NovaGray is developing a new generation of companion diagnostic tests aimed at improving radiation therapy planning. The overarching goal of NovaGray lies in the practitioner’s ability to tailor the dose and the sessions’ sequencing to the profile of his or her patient.
Phone Number +33613992898
Contact Email contact@nova-gray.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

NovaGray RILA Breast®
A test that predicts the radiosensitivity of breast cancer patients by measuring the rate of T-CD8 lymphocyte apoptosis from a blood sample.
NovaGray RILA Prostate®
A test that predicts the radiosensitivity of prostate cancer patients by measuring the rate of T-CD8 lymphocyte apoptosis from a blood sample.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant
obfuscation
Grant - NovaGray Logo
Grant - NovaGray
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - NovaGray Logo
Grant - NovaGray
—
EISMEA Logo
EISMEA
—
Grant - NovaGray Logo
Grant - NovaGray
—
EISMEA Logo
EISMEA
—
Grant - NovaGray Logo
Grant - NovaGray
—
EISMEA Logo
EISMEA
—
Grant - NovaGray Logo
Grant - NovaGray
—
EISMEA Logo
EISMEA
—
Grant - NovaGray Logo
Grant - NovaGray
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

56
-92.6%
 in past month

IT Spend

$310.6KThis year, NovaGray is projected to spend $310.6K on IT, according to Aberdeen.

Active Website Tech Count

23NovaGray is actively using 23 technologies for its website, according to BuiltWith. These include SPF, DNSSEC, and  Cloudflare CDN.

Total IP

8The intellectual property of NovaGray includes 5 registered patents primarily in the 'Testing' category, according to IPqwery. Additionally, NovaGray has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NovaGray's headquarters? NovaGray is located in Montpellier, Languedoc-Roussillon, France.Who invested in NovaGray? NovaGray has 2 investors including EISMEA and  MedTech Innovator.When was the last funding round for NovaGray? NovaGray closed its last funding round on
obfuscation
from a Grant round.Who are NovaGray's competitors? Alternatives and possible competitors to NovaGray may include SOPHiA GENETICS, Caris Life Sciences, and  Foundation Medicine.How much funding has NovaGray raised to date? NovaGray has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|